The latest market report published by Credence Research, Inc. “Neurovascular Devices Market: Growth, Future Prospects, and Competitive Analysis, 2018 - 2026” the global market for neurovascular devices was valued at US$ 1,863.0 million in 2017 and is expected to reach US$ 3,257.1 million by 2026 for a CAGR of 6.1 percent between 2018 and 2026.
Market Insights
The global market for neurovascular devices has shown productive growth over the forecast period from 2018 to 2026. Neurovascular devices (e.g. embolic coils, neurothrombectomy devices, balloon occlusion devices, clot retrievers, flow diversion devices, etc.) support the treatment of numerous neurovascular disorders such as cerebral aneurysms, cerebral artery stenosis, intracranial atherosclerotic disease, and stroke. Growing medical tourism, increasing the elderly population, the advancement of high-quality medical devices, the evolution of minimally invasive surgeries and new techniques are few external factors driving the global market. Stroke holds a major market share in the field of neurovascular devices in 2018.
Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/neurovascular-devices-market
The incidence of movement disabilities is increasing due to the upsurge in neurovascular diseases such as arteriovenous malformations and brain aneurysm, mainly in the elderly population. Commercialization and development of embolization and coiling techniques, the advancement of carotid artery angioplasty and stenting, technology support and neurothrombectomy will further boost revenue growth during the forecast period. High device costs, lack of healthcare professionals, less awareness of advanced products in developing countries and an unstructured reimbursement scenario will reduce market growth during the forecast period. The market in North America and Europe is experiencing steady growth due to the presence of multi-specialty hospitals, rehabilitation centers and the availability of trained professionals. In addition, the significant adoption of interventional neurologic devices among neurologists and the massive presence of neurovascular device manufacturers in the U.S. will drive growth globally.
Key Market Movements:
- Globally, the neurovascular devices market remains to exhibit a lucrative growth with a CAGR of 6.1% for the period from 2018 to 2026
- Based on the type, the aneurysm coiling & embolization devices segment shows lucrative growth with increasing applications in the end-user industry
- The growing number of hospitals, availability of branded devices with improved applications, and growing healthcare spending in the developing nations will further assist the overall growth of the neurovascular devices to market globally
- Major players in this vertical are Penumbra, Inc. Phenox GmbH, Stryker, Abbott Laboratories, Terumo Corporation, Merit Medical Systems, Inc., W. L. Gore & Associates, Inc., Johnson & Johnson, MicroPort Scientific Corporation, Delaware Corporation, Rapid Medical, Medtronic plc, and others
You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/59642
Key research study highlights comprise:
- Exhaustive research and analysis of the global neurovascular devices industry
- The key market segments along have been explained in the report thoroughly along with their existing and estimated market size
- Major elements of market dynamics such as drivers, challenges and opportunities and their effect on neurovascular devices market are also covered in the report
- Key players operating in the market are profiled and accompanied by the competitive landscape evaluated on the basis of product offering & business strength
- Cross-sectional analysis of each region covering individual segments for the forecast period 2018 - 2016 in terms of value (US$Mn)
The participants tracked for primary interviews include:
- Marketing/product managers
- Vice President/ CEOs
- National sales managers
- Market intelligence managers
- Distributors
- Purchasing managers
- Other stakeholders
Market Segmentation
By Type
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Neurothrombectomy Devices
- Support Devices
By Indication Segment
- Stroke
- Cerebral Artery Stenosis
- Cerebral Aneurysm
- Others
By End-user Segment
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Geography Segment
- North America (the U.S., Rest of North America)
- Europe (U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, Japan, India, Rest of Asia Pacific)
- Rest of the World (the Middle East & Africa, Latin America)
